TCI Wealth Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-204
| Closed | -$11K | – | 2349 |
|
2023
Q1 | $11K | Hold |
204
| – | – | ﹤0.01% | 1025 |
|
2022
Q4 | $10.8K | Buy |
204
+57
| +39% | +$3.02K | ﹤0.01% | 1026 |
|
2022
Q3 | $7K | Sell |
147
-24
| -14% | -$1.14K | ﹤0.01% | 1302 |
|
2022
Q2 | $10K | Buy |
171
+24
| +16% | +$1.4K | ﹤0.01% | 1042 |
|
2022
Q1 | $9K | Buy |
147
+29
| +25% | +$1.78K | ﹤0.01% | 1209 |
|
2021
Q4 | $6K | Hold |
118
| – | – | ﹤0.01% | 1592 |
|
2021
Q3 | $4K | Sell |
118
-22
| -16% | -$746 | ﹤0.01% | 1835 |
|
2021
Q2 | $6K | Buy |
140
+42
| +43% | +$1.8K | ﹤0.01% | 1361 |
|
2021
Q1 | $3K | Buy |
+98
| New | +$3K | ﹤0.01% | 1598 |
|